These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 2112659

  • 41. [Successful treatment using recombinant thrombomodulin for disseminated intravascular coagulation associated with recurrent prosthetic valve endocarditis].
    Masuda S, Adachi O, Ito K, Matsuo S, Hayatsu Y, Suzuki Y, Saito T, Akiyama M, Kumagai K, Motoyoshi N, Kawamoto S, Saiki Y.
    Kyobu Geka; 2013 Feb; 66(2):101-5. PubMed ID: 23381354
    [Abstract] [Full Text] [Related]

  • 42. Comparison of recombinant human thrombomodulin and gabexate mesylate for treatment of disseminated intravascular coagulation (DIC) with sepsis following emergent gastrointestinal surgery: a retrospective study.
    Akahoshi T, Sugimori H, Kaku N, Tokuda K, Nagata T, Noda E, Morita M, Hashizume M, Maehara Y.
    Eur J Trauma Emerg Surg; 2015 Oct; 41(5):531-8. PubMed ID: 26038004
    [Abstract] [Full Text] [Related]

  • 43. Serial changes in neutrophil-endothelial activation markers during the course of sepsis associated with disseminated intravascular coagulation.
    Gando S, Kameue T, Matsuda N, Hayakawa M, Hoshino H, Kato H.
    Thromb Res; 2005 Oct; 116(2):91-100. PubMed ID: 15907522
    [Abstract] [Full Text] [Related]

  • 44. Progression of isolated tricuspid regurgitation late after mitral valve surgery for rheumatic mitral valve disease.
    Izumi C, Iga K, Konishi T.
    J Heart Valve Dis; 2002 May; 11(3):353-6. PubMed ID: 12056726
    [Abstract] [Full Text] [Related]

  • 45. Differences in antithrombin III activities by administration method in critical patients with disseminated intravascular coagulation: a pharmacokinetic study.
    Aibiki M, Fukuoka N, Nishiyama T, Maekawa S, Shirakawa Y.
    Shock; 2007 Aug; 28(2):141-7. PubMed ID: 17515857
    [Abstract] [Full Text] [Related]

  • 46. [Contrast echocardiography in the diagnosis of tricuspid insufficiency. Evaluation before and after cardiosurgical intervention in 24 patients].
    Corallo S, Pundarò P, Mutinelli MR, Broso GP, Castelfranco M, Morandi A, Santoli C.
    G Ital Cardiol; 1986 Mar; 16(3):213-23. PubMed ID: 3732714
    [Abstract] [Full Text] [Related]

  • 47. Surgery for tricuspid regurgitation late after mitral valve replacement.
    King RM, Schaff HV, Danielson GK, Gersh BJ, Orszulak TA, Piehler JM, Puga FJ, Pluth JR.
    Circulation; 1984 Sep; 70(3 Pt 2):I193-7. PubMed ID: 6744564
    [Abstract] [Full Text] [Related]

  • 48. International Society on Thrombosis and Haemostasis score for overt disseminated intravascular coagulation predicts organ dysfunction and fatality in sepsis patients.
    Voves C, Wuillemin WA, Zeerleder S.
    Blood Coagul Fibrinolysis; 2006 Sep; 17(6):445-51. PubMed ID: 16905947
    [Abstract] [Full Text] [Related]

  • 49. [Prosthetic valve endocarditis complicated with cardiogenic shock and disseminated intravascular coagulation; report of a case].
    Yamamoto K, Shinonaga M, Takeda F, Tanaka S, Matsubara H, Oguma F, Kasuya S.
    Kyobu Geka; 2002 Aug; 55(9):807-10. PubMed ID: 12174629
    [Abstract] [Full Text] [Related]

  • 50. [Severe surgical infection and DIC].
    Tamakuma S.
    Nihon Geka Gakkai Zasshi; 1983 Sep; 84(9):878-81. PubMed ID: 6427596
    [Abstract] [Full Text] [Related]

  • 51. [Effect of surgical treatment of tricuspid regurgitation late after valve replacement of left heart].
    Hou XT, Meng X, Li W, Wang JG.
    Zhonghua Yi Xue Za Zhi; 2005 Dec 14; 85(47):3362-4. PubMed ID: 16409846
    [Abstract] [Full Text] [Related]

  • 52. Surgical strategy for severe tricuspid valve regurgitation complicated by advanced mitral valve disease: long-term outcome of tricuspid valve supra-annular implantation in eighty-eight cases.
    Ohata T, Kigawa I, Yamashita Y, Wanibuchi Y.
    J Thorac Cardiovasc Surg; 2000 Aug 14; 120(2):280-3. PubMed ID: 10917943
    [Abstract] [Full Text] [Related]

  • 53. Isolated severe ischemic tricuspid regurgitation: successful surgical repair.
    Dandekar U, Sachithanandan A, Kalkat M, Ridley P, Satur CM.
    J Heart Valve Dis; 2007 May 14; 16(3):331-2. PubMed ID: 17578057
    [Abstract] [Full Text] [Related]

  • 54. [Tricuspid valve replacement for elderly patients with isolated tricuspid valve regurgitation; report of 2 cases].
    Miyagi N, Shirai T, Oshima N.
    Kyobu Geka; 2007 Mar 14; 60(3):245-9. PubMed ID: 17352144
    [Abstract] [Full Text] [Related]

  • 55. Tricuspid valve replacement in rheumatic disease: preoperative predictors of hospital mortality.
    Poveda JJ, Bernal JM, Matorras P, Hernando JP, Oliva MJ, Ochoteco A, Berrazueta JR.
    J Heart Valve Dis; 1996 Jan 14; 5(1):26-30. PubMed ID: 8834721
    [Abstract] [Full Text] [Related]

  • 56. Mitral valve surgery for functional mitral regurgitation: should moderate-or-more tricuspid regurgitation be treated? a propensity score analysis.
    Calafiore AM, Gallina S, Iacò AL, Contini M, Bivona A, Gagliardi M, Bosco P, Di Mauro M.
    Ann Thorac Surg; 2009 Mar 14; 87(3):698-703. PubMed ID: 19231373
    [Abstract] [Full Text] [Related]

  • 57. [Studies of two cases of ruptured intracranial aneurysm with disseminated intravascular coagulation].
    Toyoda O, Nojiri K, Nakajima H.
    No Shinkei Geka; 1989 Nov 14; 17(11):1083-7. PubMed ID: 2512515
    [Abstract] [Full Text] [Related]

  • 58. Tricuspid valve surgery: a thirty-year assessment of early and late outcome.
    Guenther T, Noebauer C, Mazzitelli D, Busch R, Tassani-Prell P, Lange R.
    Eur J Cardiothorac Surg; 2008 Aug 14; 34(2):402-9; discussion 409. PubMed ID: 18579403
    [Abstract] [Full Text] [Related]

  • 59. [Report of five cases of major surgery during anticoagulant therapy after prosthetic valve replacement].
    Midorikawa H, Iwatani F, Igari T, Abe T, Hagiwara K, Tanji M, Sadogawa H, Watanabe M, Sato Y, Hoshino S.
    Kyobu Geka; 1990 Feb 14; 43(2):117-23. PubMed ID: 2106597
    [Abstract] [Full Text] [Related]

  • 60. Inhibitory effects of gabexate mesilate (FOY) on experimental DIC.
    Isobe J.
    Adv Exp Med Biol; 1979 Feb 14; 120B():385-94. PubMed ID: 229708
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.